AI assistant
Sending…
Medistim — Director's Dealing 2024
Nov 20, 2024
3662_dirs_2024-11-20_d229cc70-1ae7-48c9-b9cf-dd767ee74182.html
Director's Dealing
Open in viewerOpens in your device viewer
Notification of trade in the Medistim share
Notification of trade in the Medistim share
Tore Krogstad, related party to Medistim’s CEO Kari Krogstad, has purchased through the company Engelia Invest AS 1500 shares in Medstim ASA the 20th of November. The average price per share purchased was NOK 139.77. After the purchase, Engelia Invest AS holds 1500 Medistim shares.
More from Medistim
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
May 12
Notice of Dividend Amount
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 6
Notice of Dividend Amount
2026
May 6
Notice of Dividend Amount
2026
Apr 30
Report Publication Announcement
2026
Apr 28